{"id":"https://openalex.org/W3009603900","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5525","title":"Results of a phase II evaluation of nanoparticle albumin bound paclitaxel (nab-paclitaxel) in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer","display_name":"Results of a phase II evaluation of nanoparticle albumin bound paclitaxel (nab-paclitaxel) in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer","alternate_titles":[],"publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W3009603900","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5525","mag":"3009603900"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.5525","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5525","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.5525","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3009603900"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072788088","display_name":"Michael G. Teneriello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. G. Teneriello","raw_affiliation_strings":["US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067264448","display_name":"Paul C. Tseng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. C. Tseng","raw_affiliation_strings":["US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048278406","display_name":"Mark Crozier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Crozier","raw_affiliation_strings":["US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038347252","display_name":"Carlos A. Encarnacion","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Encarnacion","raw_affiliation_strings":["US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111812876","display_name":"K. C. Hancock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Hancock","raw_affiliation_strings":["US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025557125","display_name":"Mark J. Messing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. J. Messing","raw_affiliation_strings":["US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047894550","display_name":"Kristi A. Boehm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. A. Boehm","raw_affiliation_strings":["US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Williams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Williams","raw_affiliation_strings":["US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053161145","display_name":"Des Ilegbodu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Ilegbodu","raw_affiliation_strings":["US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028916394","display_name":"Lina Asmar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Asmar","raw_affiliation_strings":["US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research, Houston, TX; Texas Oncology, Austin, TX; Northwest Gynecologic Oncology, Portalnd, OR; Texas Oncology, Waco, TX; Texas Oncology, Ft. Worth, TX; US Oncology Research, Inc., Houston, TX","institution_ids":["https://openalex.org/I2800124591"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2800124591"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"5525","last_page":"5525"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9490000009536743},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.8659999966621399},{"id":"https://openalex.org/keywords/platinum-sensitive-disease","display_name":"platinum-sensitive disease","score":0.9269999861717224},{"id":"https://openalex.org/keywords/recist-criteria","display_name":"RECIST criteria","score":0.7990000247955322},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.8199999928474426},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8289999961853027},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.7940000295639038},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.5139999985694885},{"id":"https://openalex.org/keywords/epithelial-ovarian-cancer","display_name":"epithelial ovarian cancer","score":0.6740000247955322},{"id":"https://openalex.org/keywords/peritoneal-cancer","display_name":"peritoneal cancer","score":0.621999979019165},{"id":"https://openalex.org/keywords/fallopian-tube-cancer","display_name":"fallopian tube cancer","score":0.9629999995231628},{"id":"https://openalex.org/keywords/survival-outcomes","display_name":"survival outcomes","score":0.3319999873638153}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9124690890312195},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7767477035522461},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7132773399353027},{"id":"https://openalex.org/C2777249960","wikidata":"https://www.wikidata.org/wiki/Q4818922","display_name":"Fallopian tube cancer","level":4,"score":0.6427097320556641},{"id":"https://openalex.org/C2775883341","wikidata":"https://www.wikidata.org/wiki/Q1233836","display_name":"Fallopian tube","level":2,"score":0.6275460720062256},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5234550833702087},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5070929527282715},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.5060648322105408},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4922620356082916},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.43867599964141846},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.43142253160476685},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3774375915527344},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3767619729042053},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3586235046386719},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3403811454772949},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.5525","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5525","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.5525","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2152175544","https://openalex.org/W2261143623","https://openalex.org/W2050995852","https://openalex.org/W2046940607","https://openalex.org/W2381956719","https://openalex.org/W1898709837","https://openalex.org/W2341250343","https://openalex.org/W2019229840","https://openalex.org/W4321446230","https://openalex.org/W2201835601"],"abstract_inverted_index":{"5525":[0],"Background:":[1],"Patients":[2],"(pts)":[3],"with":[4,17,30,44,190,289],"recurrent":[5,33,290],"ovarian,":[6,291],"peritoneal,":[7,292],"or":[8,62,72,86,142,293],"fallopian":[9,70,294],"tube":[10,295],"cancer":[11,66],"generally":[12],"have":[13],"a":[14,125,333],"poor":[15],"outcome":[16],"current":[18],"therapies.":[19],"There":[20],"are":[21,36,270,318,324],"no":[22],"reports":[23],"of":[24,67,94,105,113,127,287,312,315,322],"albumin-bound":[25],"paclitaxel":[26],"(nab-paclitaxel)":[27],"in":[28,46,91,167,185,201,222,257,284,330],"pts":[29,51,154,171,189,205,269,288],"platinum":[31],"sensitive":[32],"disease.":[34,278],"We":[35],"reporting":[37],"our":[38],"preliminary":[39],"efficacy":[40],"and":[41,81,148,164,182,198,209,219,246,249,304,307,310],"toxicity":[42],"results":[43],"nab-paclitaxel":[45,106,323],"this":[47,285],"group.":[48],"Methods:":[49],"47":[50],"were":[52,263,302],"enrolled":[53],"(44":[54],"available":[55],"for":[56],"analysis).":[57],"Main":[58],"inclusion":[59],"criteria:":[60],"histologically":[61],"cytologically":[63],"confirmed":[64],"epithelial":[65],"the":[68,92,155,176,212,313],"ovary,":[69],"tube,":[71],"peritoneum":[73],"(any":[74],"stage,":[75],"grade":[76],"2\u20133":[77],"if":[78],"stage":[79],"I)":[80],"measurable":[82,95],"disease":[83,98,121,316],"by":[84,173],"RECIST":[85,174,208],"elevated":[87],"CA-125":[88,210],"(>70":[89],"units/mL)":[90],"absence":[93],"disease;":[96],"nonepithelial":[97],"was":[99,133,160,178,194,214,229,274,281,299,328],"excluded.":[100],"Pts":[101,117],"received":[102],"260":[103],"mg/m2":[104],"IV":[107,143],"over":[108],"30":[109],"minutes":[110],"Day":[111],"1":[112,233],"each":[114],"21-day":[115],"cycle.":[116],"continued":[118],"until":[119],"progressive":[120,277],"(PD)":[122],"up":[123],"to":[124,227,234,276],"maximum":[126],"6":[128],"cycles.":[129],"Results:":[130],"Median":[131,225],"age":[132],"65.5":[134],"years":[135],"(range,":[136,232],"42-":[137],"84),":[138],"Stage":[139],"IIIC":[140],"(53%)":[141],"(23%);":[144],"ECOG":[145],"PS=0":[146],"(87%),":[147],"prior":[149],"surgery":[150],"(94%).":[151],"For":[152],"evaluable":[153],"overall":[156],"response":[157,228],"rate":[158],"(ORR)":[159],"50%":[161],"(13":[162],"CR":[163,181,197,218],"9":[165],"PR":[166,184,200,221],"44":[168],"pts).":[169,187,203],"In":[170,188,204],"followed":[172],"only,":[175],"ORR":[177,213,298],"27%":[179],"(1":[180],"2":[183,199],"11":[186,202],"only":[191],"CA-125,":[192],"it":[193],"64%":[195],"(5":[196],"meeting":[206],"both":[207],"criteria,":[211],"54.5":[215],"%":[216],"(7":[217],"5":[220],"22":[223],"pts.":[224],"time":[226],"1.8":[230],"months":[231],"2.1).":[235],"The":[236,297],"most":[237],"frequent":[238],"Grade":[239,264],"3\u20134":[240],"treatment-related":[241],"toxicities":[242],"were:":[243],"neutropenia":[244],"(8.7%)":[245],"fatigue,":[247],"diarrhea,":[248],"dyspepsia":[250],"(2.2%,":[251],"each);":[252],"alopecia":[253],"(Grades":[254],"1\u20132)":[255],"occurred":[256],"84.8%.":[258],"All":[259],"other":[260],"adverse":[261],"events":[262],"1\u20132.":[265],"To":[266],"date,":[267],"46":[268],"surviving;":[271],"one":[272],"death":[273],"related":[275],"Conclusions:":[279],"Nab-paclitaxel":[280],"very":[282],"active":[283],"group":[286],"cancer.":[296],"50%.":[300],"Toxicities":[301],"minimal":[303],"manageable.":[305],"Response":[306],"survival":[308],"analysis":[309],"review":[311],"methods":[314],"assessment":[317],"ongoing.":[319],"Further":[320],"studies":[321],"warranted.":[325],"This":[326],"research":[327,334],"supported,":[329],"part,":[331],"from":[332,336],"grant":[335],"Abraxis":[337],"BioScience,":[338],"Inc.,":[339],"Santa":[340],"Monica,":[341],"CA.":[342],"[Table:":[343],"see":[344],"text]":[345]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3009603900","counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2020-03-13T00:00:00"}
